Here's how DOI.ORG makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

DOI . ORG {}

Detected CMS Systems:

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Doi.org Make Money
  6. Keywords
  7. Topics
  8. Social Networks
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. Hosting Providers
  13. CDN Services

We began analyzing https://journals.lww.com/ajsp/fulltext/2009/05000/even_low_level_her2_expression_may_be_associated.11.aspx, but it redirected us to https://journals.lww.com/ajsp/fulltext/2009/05000/even_low_level_her2_expression_may_be_associated.11.aspx. The analysis below is for the second page.

Title[redir]:
The American Journal of Surgical Pathology
Description:
ng HER2 as a prognostic marker. Recent data using quantitative image analysis suggest that both high and low HER2 expression are associated with poor clinical outcome. Using the immunohistochemical scoring criteria currently recommended by the College of American Pathologists and American Society of Clinical Oncology to help select patients for trastuzumab, we evaluated HER2 protein expression in tumor tissue microarrays of 91 node-positive patients with invasive breast carcinoma treated with mastectomy and doxorubicin-based chemotherapy without trastuzumab and without irradiation with a median follow-up of 12.5 years. A wide range of HER2 expression (HER2 ≥1+) in the primary tumor was significantly associated with decreased locoregional recurrence-free survival (P=0.014), decreased disease-specific survival (P=0.001), and decreased overall survival (P=0.001). Even in the subset considered HER2 negative by current College of American Pathologists and American Society of Clinical Oncology guidelines, HER2=1+ was associated with worse outcome than HER2=0 in this patient cohort. The association between HER2 ≥1+ and worse outcome had the greatest statistical significance in the hormone receptor-positive subset of patients. These findings support the hypothesis that low-level HER2 expression may have significant clinical implications. Although the assessment of HER2 expression is most important for predicting response to anti-HER2 therapy, detection of low-level HER2 expression might also be useful in helping to select a more aggressive treatment regimen for patients ineligible for anti-HER2 therapy....

Matching Content Categories {📚}

  • Education
  • Science
  • Health & Fitness

Content Management System {📝}

What CMS is doi.org built with?


Doi.org is based on MYBB.

Traffic Estimate {📈}

What is the average monthly size of doi.org audience?

🌍 Impressive Traffic: 500k - 1M visitors per month


Based on our best estimate, this website will receive around 600,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Doi.org Make Money? {💸}

We don't see any clear sign of profit-making.

Not all websites focus on profit; some are designed to educate, connect people, or share useful tools. People create websites for numerous reasons. And this could be one such example. Doi.org might have a hidden revenue stream, but it's not something we can detect.

Keywords {🔍}

patients, survival, expression, tumor, breast, clinical, primary, decreased, lymph, therapy, study, outcome, staining, versus, locoregional, prognostic, ihc, node, lowlevel, nodepositive, analysis, diseasespecific, cancer, trastuzumab, antiher, recurrencefree, negative, tissue, chemotherapy, significance, year, response, tumors, studies, actuarial, treated, positive, positivity, metastases, found, protein, followup, patient, pbs, journal, evaluated, association, metastasis, date, american,

Topics {✒️}

locoregional recurrence-free survival locoregional recurrence-free node-positive breast cancer decreased disease-specific survival hormone receptor-positive subset improved disease-specific survival hormone receptor-positive patients manual tissue puncher/array locoregional disease recurrence low-level her2 expression node-positive patient cohort lymph node-positive patients receive anti-her2 therapy 2-sided log-rank test doxorubicin-based chemotherapy regimen high-level her2 expression hormone receptor expression increased tumor recurrence decreased disease-specific disease-specific survival low-level expression journal authors submit lymph node metastases reduce background due view full text invasive breast carcinomas invasive breast carcinoma lymph node metastasis quantitative image analysis invasive breast cancer invasive breast cancers operable breast carcinoma hormone receptor status receive systemic therapy positive lymph nodes node-positive cohort log-rank test multiple clinicopathologic variables primary breast carcinomas locoregional recurrence explicit scoring criteria anderson cancer center cox multivariate analysis drug administration approval phosphate buffered saline bright field microscopy multiple clinicopathologic characteristics trial originally designed phase iii trial castaneda-soto nj

Social Networks {👍}(1)

External Links {🔗}(111)

Analytics and Tracking {📊}

  • Comscore
  • Google Analytics
  • Google Tag Manager

Libraries {📚}

  • Bootstrap
  • FontAwesome
  • jQuery
  • Zoom.js

Emails and Hosting {✉️}

Mail Servers:

  • mx.zoho.eu
  • mx2.zoho.eu
  • mx3.zoho.eu

Name Servers:

  • josh.ns.cloudflare.com
  • zita.ns.cloudflare.com

CDN Services {📦}

  • Cookielaw
  • Jsdelivr
  • Scite
  • Wolterskluwer

5.23s.